Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
4.950
0.00 (0.00%)
At close: May 22, 2026, 4:00 PM EDT
4.520
-0.430 (-8.69%)
Pre-market: May 26, 2026, 4:47 AM EDT
Aptevo Therapeutics Employees
Aptevo Therapeutics had 33 employees as of December 31, 2025. The number of employees decreased by 4 or -10.81% compared to the previous year.
Employees
33
Change (1Y)
-4
Growth (1Y)
-10.81%
Revenue / Employee
n/a
Profits / Employee
-$792,697
Market Cap
5.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33 | -4 | -10.81% |
| Dec 31, 2024 | 37 | -3 | -7.50% |
| Dec 31, 2023 | 40 | -5 | -11.11% |
| Dec 31, 2022 | 45 | -9 | -16.67% |
| Dec 31, 2021 | 54 | -4 | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| CollPlant Biotechnologies | 39 |
| BiomX | 20 |
| Virax Biolabs Group | 19 |
| FibroBiologics | 15 |
| TransCode Therapeutics | 12 |
| XTL Biopharmaceuticals | 10 |
| Silo Pharma | 3 |
APVO News
- 12 days ago - Aptevo Therapeutics reports Q1 cash and cash equivalents $14.5M - TheFly
- 12 days ago - Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection - Accesswire
- 19 days ago - Aptevo reports 87% clinical benefit in frontline AML patients in RAINIER trial - TheFly
- 19 days ago - Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection - Accesswire
- 2 months ago - Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year - TheFly
- 2 months ago - Aptevo Therapeutics sees cash runway into 4Q26 - TheFly
- 2 months ago - Aptevo Provides State of the Business Report and 2025 Financial Results - Accesswire
- 2 months ago - Aptevo to Participate in March 2026 Conferences - Accesswire